重置肾上腺意外瘤伴轻度自主皮质醇分泌患者的异常昼夜皮质醇节律
这项1/2a期前瞻性研究纳入6例肾上腺意外瘤伴自主皮质醇分泌(AI/ACS)患者及两组各6例匹配对照,发现患者傍晚至凌晨皮质醇暴露增高;
要点
- 治疗前升高的IL-6在治疗后恢复正常。
核心结论
- AI/ACS患者傍晚和夜间皮质醇暴露增加,定时晚间给予美替拉酮可将皮质醇节律重置至正常,并与心血管风险标志物IL-6降低相关。
研究设计与样本
- 1/2a期前瞻性研究(Eudract no. 2012-002586-35),纳入6例AI/ACS患者及两组各6例性别、年龄和体重指数匹配的对照:AI/NoACS组和健康对照(HC)组。
- 进行24小时昼夜皮质醇分析以确定组间差异及使用11β-羟化酶抑制剂美替拉酮降低皮质醇的干预时机,并评估血清IL-6的昼夜特征。
临床怎么用
- 作者认为,在AI/ACS中傍晚和夜间皮质醇暴露增加,定时晚间给予美替拉酮可将皮质醇节律重置至正常,并与心血管风险标志物IL-6降低相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Adrenal incidentalomas (AIs) are found commonly on axial imaging. Around 30% exhibit autonomous cortisol secretion (ACS) associated with increased cardiovascular events and death. OBJECTIVE: We hypothesized that AI/ACS patients have an abnormal cortisol rhythm that could be reversed by use of carefully timed short-acting cortisol synthesis blockade, with improvement in cardiovascular disease markers. DESIGN, SETTING, AND PARTICIPANTS: In a phase 1/2a, prospective study (Eudract no. 2012-002586-35), we recruited six patients with AI/ACS and two control groups of six sex-, age-, and body mass index-matched individuals: (1) patients with AI and no ACS (AI/NoACS) and (2) healthy volunteers with no AI [healthy controls (HC)]. Twenty-four-hour circadian cortisol analysis was performed to determine any differences between groups and timing of intervention for cortisol lowering using the 11β-hydroxylase inhibitor metyrapone. Circadian profiles of serum interleukin-6 (IL-6) were assessed. RESULTS: Serum cortisol levels in group AI/ACS were significantly higher than both group AI/NoACS and group HC from 6 pm to 10 pm [area under the curve (AUC) difference: 0.81 nmol/L/h; P = 0.01] and from 10 pm to 2 am (AUC difference: 0.86 nmol/L/h; P < 0.001). In light of these findings, patients with ACS received metyrapone 500 mg at 6 pm and 250 mg at 10 pm, and cortisol rhythms were reassessed. Postintervention evening serum cortisol was lowered, similar to controls [6 pm to 10 pm (AUC difference: -0.06 nmol/L/h; P = 0.85); 10 pm to 2 am (AUC difference: 0.10 nmol/L/h; P = 0.76)]. Salivary cortisone showed analogous changes. IL-6 levels were elevated before treatment [10 pm to 2 pm (AUC difference: 0.42 pg/mL/h; P = 0.01)] and normalized post treatment. CONCLUSIONS: In AI/ACS, the evening and nocturnal cortisol exposure is increased. Use of timed evening doses of metyrapone resets the cortisol rhythm to normal. This unique treatment paradigm is associated with a reduction in the cardiovascular risk marker IL-6.
引用
- Debono M, Harrison RF, Chadarevian R, et al. Resetting the Abnormal Circadian Cortisol Rhythm in Adrenal Incidentaloma Patients With Mild Autonomous Cortisol Secretion. J Clin Endocrinol Metab. 2017. PMID: 28911138. doi:10.1210/jc.2017-00823
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。